{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:38:48Z","timestamp":1782131928824,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lungcan.2025.108789","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:52:12Z","timestamp":1760223132000},"page":"108789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3262-3808","authenticated-orcid":false,"given":"Richard T.","family":"Roden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-8153","authenticated-orcid":false,"given":"Jenesse N.","family":"Moffett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3193-4565","authenticated-orcid":false,"given":"Sydney D.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-2341","authenticated-orcid":false,"given":"Kenneth R.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda I.","family":"Garces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Merrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann N.","family":"Sarkaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-3202","authenticated-orcid":false,"given":"Dawn","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lungcan.2025.108789_b0005","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.chest.2021.12.655","article-title":"Distribution, risk factors, and temporal trends for lung cancer incidence and mortality: a global analysis","volume":"161","author":"Huang","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2025.108789_b0010","doi-asserted-by":"crossref","unstructured":"G.J. Riely, D.E. Wood, D.S. Ettinger, D.L. Aisner, W. Akerley, J.R. Bauman, A. Bharat, D.S. Bruno, J.Y. Chang, L.R. Chirieac, M. DeCamp, A.P. Desai, T.J. Dilling, J. Dowell, G.A. Durm, S. Gettinger, T.E. Grotz, M.A. Gubens, A. Juloori, R.P. Lackner, M. Lanuti, J. Lin, B.W. Loo, C.M. Lovly, F. Maldonado, E. Massarelli, D. Morgensztern, T.C. Mullikin, T. Ng, D. Owen, D.H. Owen, S.P. Patel, T. Patil, P.M. Polanco, J. Riess, T.A. Shapiro, A.P. Singh, J. Stevenson, A. Tam, T. Tanvetyanon, J. Yanagawa, S.C. Yang, E. Yau, K.M. Gregory, L. Hang, Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw 22(4) (2024) 249-274.","DOI":"10.6004\/jnccn.2204.0023"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108789_b0015","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtho.2020.02.005","article-title":"A primer on interstitial lung disease and thoracic radiation","volume":"15","author":"Goodman","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108789_b0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.19630","article-title":"Interstitial lung disease and risk of lung cancer","volume":"8","author":"Xu","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.lungcan.2025.108789_b0025","article-title":"Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment","volume":"11","author":"Althobiani","year":"2024","journal-title":"Front. Med. (lausanne)"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108789_b0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12931-019-1022-1","article-title":"The natural history of progressive fibrosing interstitial lung diseases","volume":"20","author":"Kolb","year":"2019","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108789_b0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.rcl.2022.06.010","article-title":"Diagnosis and treatment of lung cancer in the setting of interstitial lung disease","volume":"60","author":"Fisher","year":"2022","journal-title":"Radiol. Clin. North Am."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108789_b0040","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01164-2018","article-title":"Procedure volume and mortality after surgical lung biopsy in interstitial lung disease","volume":"53","author":"Fisher","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108789_b0045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.athoracsur.2022.05.069","article-title":"Complications and Survival after Lung Cancer Resection in Interstitial Lung Disease","volume":"115","author":"Fujiwara","year":"2023","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108789_b0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13019-024-02508-1","article-title":"Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection","volume":"19","author":"Huang","year":"2024","journal-title":"J. Cardiothorac. Surg."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108789_b0055","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/j.clon.2022.01.043","article-title":"Is Thoracic radiotherapy an absolute contraindication for treatment of lung cancer patients with interstitial lung disease? a systematic review","volume":"34","author":"Saha","year":"2022","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"11","key":"10.1016\/j.lungcan.2025.108789_b0060","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.21873\/anticanres.15379","article-title":"Hypofractionated proton beam therapy for cT1-2N0M0 non-small cell lung cancer patients with interstitial lung disease","volume":"41","author":"Saito","year":"2021","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108789_b0065","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaoncol.2023.7269","article-title":"Stereotactic radiation therapy in early non-small cell lung cancer and interstitial lung disease: a nonrandomized clinical trial","volume":"10","author":"Palma","year":"2024","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108789_b0070","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.21037\/jtd-20-2501","article-title":"Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations","volume":"13","author":"Chiang","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"15","key":"10.1016\/j.lungcan.2025.108789_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153627","article-title":"Proton beam therapy versus photon radiotherapy for stage I non-small cell lung cancer","volume":"14","author":"Suh","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108789_b0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13014-019-1221-4","article-title":"Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy","volume":"14","author":"Kim","year":"2019","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2025.108789_b0085","first-page":"37","article-title":"Pro-con of proton: dosimetric advantages of intensity-modulation over passive scatter for thoracic malignancies, Tech Innov Patient support","volume":"15","author":"Jie","year":"2020","journal-title":"Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108789_b0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijrobp.2009.04.028","volume":"77","author":"Zhang","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2025.108789_b0095","doi-asserted-by":"crossref","unstructured":"F.C. Detterbeck, D.J. Boffa, A.W. Kim, L.T. Tanoue, The Eighth Edition Lung Cancer Stage Classification, Chest 151(1) (2017) 193-203.","DOI":"10.1016\/j.chest.2016.10.010"},{"key":"10.1016\/j.lungcan.2025.108789_b0100","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50. (Accessed June 25 2024)."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108789_b0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.athoracsur.2023.04.042","article-title":"Association between interstitial lung disease and outcomes after lung cancer resection","volume":"116","author":"Axtell","year":"2023","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108789_b0110","article-title":"Lung cancer resection in patients with underlying usual interstitial pneumonia: a meta-analysis","volume":"10","author":"Patel","year":"2023","journal-title":"BMJ Open Respir. Res."},{"issue":"10","key":"10.1016\/j.lungcan.2025.108789_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140437","article-title":"Impact of preexisting interstitial lung disease on acute, extensive radiation pneumonitis: retrospective analysis of patients with lung cancer","volume":"10","author":"Ozawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2025.108789_b0120","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.2147\/COPD.S210759","article-title":"Impact of underlying pulmonary diseases on treatment outcomes in early-stage non-small cell lung cancer treated with definitive radiotherapy","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108789_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061445","article-title":"Prospective study of proton therapy for lung cancer patients with poor lung function or pulmonary fibrosis","volume":"14","author":"Noh","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108789_b0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13014-022-02027-0","article-title":"Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia","volume":"17","author":"Hashimoto","year":"2022","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108789_b0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.prro.2016.01.009","article-title":"Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease","volume":"6","author":"Bahig","year":"2016","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108789_b0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/JTO.0000000000000359","article-title":"Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer","volume":"10","author":"Ueki","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108789_b0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13014-021-01780-y","article-title":"Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities","volume":"16","author":"Kobayashi","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108789_b0155","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2023.02.030","article-title":"Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis","volume":"116","author":"Rimner","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108789_b0160","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108789_b0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2016.04.033","article-title":"A voxel-based approach to explore local dose differences associated with radiation-induced lung damage","volume":"96","author":"Palma","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T04:45:05Z","timestamp":1762490705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225006816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"alternative-id":["S0169500225006816"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108789","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108789"}}